Prat et al. reported considerably reduced seroprotective levels after HBV vaccinations (HBsAb ≥ 10 and 100 IU/L) among IBD patients receiving anti-TNF therapy (46.3%; P < 0.01) than those who did not. Here, TNF is linked to inflammatory bowel disease.